Selank

Buy Selank Peptide: Research-Grade Heptapeptide for Neurological Studies

Are you looking to buy Selank peptide from a manufacturer that verifies purity on every batch? Sino Research Peptide Manufacturer supplies Selank, a short synthetic heptapeptide composed of seven amino acids. Researchers developed Selank to mimic the naturally occurring peptide Tuftsin,(5) a short IgG fragment involved in immune system regulation.

What Is Selank Peptide?

After discovering and isolating Tuftsin, researchers suggested this peptide might be involved in phagocytic cell functions, including phagocytosis, motility, and immunological cell activity.(2) Since then, laboratories have synthesized various Tuftsin analogs using conventional and polymeric reagent methods.(4)

Selank’s Structure: Why It May Cross the Blood-Brain Barrier

Buy Selank Pep consists of two fragments: Tuftsin at the N-terminus and a tripeptide Pro-Gly-Pro (PGP) at the C-terminal end. Researchers believe the PGP sequence may enhance the peptide’s ability to penetrate biological barriers, including the blood-brain barrier (BBB) — the highly selective membrane separating circulating blood from brain tissue and central nervous system extracellular fluid.

Integrating PGP may modify Selank’s hydrophilicity or lipophilicity, potentially increasing compatibility with the BBB’s lipid-rich environment. The PGP motif might also interact with BBB transport systems or receptors, potentially facilitating receptor-mediated endocytosis or active transport — mechanisms that could allow Selank to bypass the tight junctions that typically block larger molecules. Researchers also suggest PGP may alter Selank’s tertiary structure, potentially making the peptide more amenable to traversing the BBB through changes in spatial configuration.(6)

Chemical Makeup of Selank

Buy Selank Peptide Research and Clinical Studies

Selank and BDNF Levels

Research suggests Selank may influence brain-derived neurotrophic factor (BDNF) expression, a protein considered crucial for neuronal survival and growth.(1) Studies indicate Selank may markedly increase BDNF mRNA levels in the hippocampus, a brain region central to memory and emotional response. This potential to boost BDNF expression — particularly under stress and glucocorticoid conditions that typically suppress BDNF — suggests relevance for research into neuroplasticity decline and synaptic function.

Selank and Serotonin Signaling

Research suggests Selank may influence serotonin signaling mechanisms tied to mood and anxiety regulation. Studies using murine models with inhibited serotonin synthesis indicate Selank might alter serotonin levels when the serotonergic system is impaired. Researchers propose Selank may boost serotonin metabolism in the brainstem, specifically increasing metabolic processing in brain regions essential for mood and anxiety regulation — suggesting a potential pathway through which Selank might address diminished serotonin activity.

Selank and GABA Signaling

Studies suggest Selank may act on gamma-aminobutyric acid (GABA) receptors, an inhibitory neurotransmitter associated with reduced neuronal excitability, relaxation, and anxiety mitigation in animal models. One study examined expression of 84 neurotransmission-related genes in murine models exposed to either Selank or GABA, analyzed via PCR after one and three hours.(7)

All studied gene expressions for Selank and GABA appeared positively correlated, suggesting Selank may induce neurotransmission alterations by modulating the GABAergic system. Research also indicates Selank’s influence might extend beyond direct GABA receptor gene transcription into allosteric modulation, inferred from differential gene expression patterns compared to GABA exposure alone. This suggests a more complex GABAergic interaction than typical direct receptor activation, potentially explaining Selank’s extended anxiolytic actions observed in experimental frameworks.

Selank and Genome Expression

Studies examined Selank’s potential impact on genome expression and inflammatory processes in male murine models weighing 250 grams, divided into control, single-exposure, and routine-exposure groups.(8) After isolating RNA from rat spleen and hippocampus tissue and analyzing it via PCR, researchers suggested Selank might impact gene expression most definitively in the spleen and hippocampus. One notable finding involved CX3CR1 gene expression changes, a gene involved in inflammatory processes — suggesting Selank may regulate inflammation through this gene expression mechanism.

Selank and Enkephalin Signaling

A clinical study examined 62 research models of Generalized Anxiety Disorder (GAD), dividing them between Selank exposure (48%) and a generic benzodiazepine compound (52%).(9) Psychometric analysis showed Selank’s impact appeared similar to the generic compound.

Researchers also reported that tau leu-enkephalin levels were apparently reduced in the Selank-exposed group before the experiment, and Selank addition may have reversed this observation. Selank is hypothesized to suppress enzymes that break down enkephalins — endogenous opioid receptor ligands implicated in pain, mood, and stress regulation. This potential enzyme inhibition might increase enkephalin levels, potentially augmenting their physiological actions during anxiety model experiments.

Selank and Memory Research

A study enrolled murine models in a four-day training session for conditioned avoidance response (CAR) learning, beginning Selank exposure 15 minutes before each day’s training session.(11) Researchers observed that learning abilities appeared to improve with each peptide exposure, with reduced errors and increased correct solutions.

This potential impact may involve multiple interconnected pathways, including neuropeptide system modulation tied to cognitive function, altered neural circuits involved in memory consolidation, and enhanced synaptic stability. Selank might also indirectly boost cognitive performance by mitigating anxiety-related factors that commonly impede learning efficiency, potentially promoting neural plasticity in underperforming cognitive circuits.

Selank and Immunomodulation Research

A clinical study examined research models of GAD with neurasthenia, comparing control and Selank-exposed groups over 14 days.(12) Peripheral blood sample analysis showed peak elevation in IL-6 cytokine levels and changes in the Th1/Th2 cytokine ratio, both considered important immune system regulators.

Selank and Withdrawal Research

Murine models received 10% ethanol as their sole fluid source for 24 weeks, inducing alcohol withdrawal symptoms once researchers removed the ethanol drip.(13) After exposing these models to Selank, researchers reported reduced withdrawal symptoms after 48 hours, based on social interaction and maze test results.

Selank and Cardiovascular Activity Research

Researchers presented Selank to feline models to examine cardiovascular and respiratory potential.(14) Results showed a 32% decrease in arterial blood pressure within 3 minutes of exposure, alongside a 24% increase in cerebral blood flow within the first 10 minutes that gradually decreased to optimal levels. Researchers noted no apparent action on the respiratory system or heart rate.

Selank and Weight, Cholesterol Research

Murine models followed a high-fat diet for 6 weeks until reaching 280–300g, then divided into control (sodium chloride) and experimental (Selank) groups, alongside an unexposed monitoring group.(15) The Selank group showed decreased cholesterol and fat levels between 25% and 58%, along with reductions in LDL, VLDL cholesterol, and triglycerides — suggesting a possible role in lipid metabolism with hypocholesterolemic and hypolipidemic actions.

Researchers also noted improvements in hemostasis parameters, including elevated total fibrinolytic activity and decreased platelet aggregation, alongside possible modulatory action on glucose homeostasis. The Selank group’s fat metabolism rate improved to match control model rates, and while control models gained an average of 40g throughout the study, the Selank group maintained stable weight with gradual reduction following peptide exposure.

Where to Buy Selank Peptide

Selank Peptide For Sale at Sino Research Peptide Manufacturer

When you compare where to buy Selank peptide, purity documentation and batch consistency should top your checklist. Sino Research Peptide Manufacturer verifies identity and purity on every batch.

Buy Selank Peptide Online With Confidence

Whether your research focuses on neuroplasticity, serotonin signaling, or GABAergic modulation, Sino Research Peptide Manufacturer ships high-purity Selank backed by rigorous internal quality checks.

Semax and Selank Together: Comparative Research

Researchers studying neuropeptide signaling often compare Selank alongside Semax, another short peptide studied for CNS and cognitive research applications. Since both peptides target overlapping neurological pathways through distinct mechanisms, many labs order them together to build comparative data across neuropeptide research models.

Order / Buy Selank Peptide Today

Ready to add Selank to your research pipeline? Sino Research Peptide Manufacturer makes ordering straightforward, with consistent, research-grade material for every study.

Selank peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering. If you buy Selank peptide above $500 from Sino Research Peptide Manufacturer you get free shipping

Referenced Citations

• Ashmarin IP, et al. (2005). Design and study of a novel immunomodulatory peptide, Selank. Russian Journal of Bioorganic Chemistry.
• Kozlovskaya MM, et al. (2000). The anxiolytic effect of Selank on experimental models of anxiety. Neuroscience and Behavioral Physiology.
• Zozulya AA, et al. (2008). The influence of Selank on anxiety and depression in patients with generalized anxiety disorder. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova.
• Medvedev VE, et al. (2014). Selank in the therapy of patients with anxiety disorders. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova.